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Abstract
Tissue engineering and regenerative medicine (TERM) approaches may provide alternatives for gastrointestinal tissue in
urinary diversion. To continue to clinically translatable studies, TERM alternatives need to be evaluated in (large) controlled
and standardized animal studies. Here, we investigated all evidence for the efficacy of tissue engineered constructs in
animal models for urinary diversion. Studies investigating this subject were identified through a systematic search of three
different databases (PubMed, Embase and Web of Science). From each study, animal characteristics, study characteristics
and experimental outcomes for meta-analyses were tabulated. Furthermore, the reporting of items vital for study
replication was assessed. The retrieved studies (8 in total) showed extreme heterogeneity in study design, including animal
models, biomaterials and type of urinary diversion. All studies were feasibility studies, indicating the novelty of this field.
None of the studies included appropriate control groups, i.e. a comparison with the classical treatment using GI tissue. The
meta-analysis showed a trend towards successful experimentation in larger animals although no specific animal species
could be identified as the most suitable model. Larger animals appear to allow a better translation to the human situation,
with respect to anatomy and surgical approaches. It was unclear whether the use of cells benefits the formation of a neo
urinary conduit. The reporting of the methodology and data according to standardized guidelines was insufficient and
should be improved to increase the value of such publications. In conclusion, animal models in the field of TERM for urinary
diversion have probably been chosen for reasons other than their predictive value. Controlled and comparative long term
animal studies, with adequate methodological reporting are needed to proceed to clinical translatable studies. This will aid
in good quality research with the reduction in the use of animals and an increase in empirical evidence of biomedical
research.
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Introduction
Urinary diversion with gastrointestinal (GI) tissue remains the
gold standard treatment for patients suffering from end-stage
bladder disease caused by bladder cancer or congenital malfor-
mations, e.g. bladder exstrophy or spina bifida [1,2]. There are
three approaches to create a urinary diversion in these patients.
The first and most commonly used type among surgeons is the
incontinent ileocutaneostomy; a urinary conduit with a skin-outlet.
Alternatively, continent diversions can be formed non-orthotop-
ically with a skin-outlet or orthotopically as a neobladder [3,4].
Although the use of GI tissue provides a satisfactory outcome in
most cases, it can be associated with severe complications. These
can be either related to the bowel surgery (obstruction, infections,
fistulas, etc.) or to the urostomy implantation (metabolic disorders,
stone formations, infections, etc.) [5,6].
A tissue engineering and regenerative medicine (TERM)
approach may provide new possibilities by creating a man-made
construct to replace GI tissue for urinary diversions. The
implementation of such constructs could prevent invasive bowel
surgery and the potentially life-threatening complications, there-
fore reducing health care costs. Several investigators have focused
on the development of new materials for this purpose, including
naturally derived materials, synthetic polymers and decellularized
scaffolds [7–9]. These biomaterials can be applied with and
without autologous cells, using the regenerative capacity of the
body [10,11].
In the field of urogenital reconstruction, bladder domes for
cystoplasty and uretheral reconstruction with man-made con-
structs have already been used in patients [12,13]. However,
despite the progress in in vitro research and animal experimenta-
tion, clinical translation of TERM approaches for urinary
diversion has been negligible. Translation from bench to bedside
for these tissue engineered constructs starts with the analysis of
biodegradability, biocompatibility and foreign body response,
which is usually performed in small rodents. To engineer and
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regenerate specific tissues, evaluation should preferably be
performed at relevant anatomical sites with appropriately sized
constructs to permit easy clinical translation. Large animal models
closely mimicking the human body are therefore desirable, but
their use might be ethically debatable [14]. In general, the choice
of an animal model is dependent on financial considerations, the
investigators experience, ethical sensitivity and practical limita-
tions. Even though other and better translatable models might be
available [15]. To our knowledge a superior animal for tissue
engineering and urinary diversion has not been identified yet.
To decide on the most suitable type of animal model an
evidenced-based systematic review is essential, since it potentially
increases the chance of successful clinical translation [16,17]. We
therefore systematically searched the current literature for all types
of studies on the efficacy of tissue engineered constructs in animal
models for urinary diversion. The results were analyzed with
respect to survival, side effects, functionality and urothelium
formation, to investigate whether there was sufficient evidence to
decide if any animal model was superior for evaluating tissue
engineered constructs for urinary diversion applications.
Materials and Methods
1. Search strategy
We identified relevant studies, including peer reviewed articles
and (congress) abstracts, through a systematic search of PubMed,
EMBASE (OvidSP) and Web of Science up until the 23rd of
January 2013, following the approach as described by de Vries
et al., and Leenaars et al. [16,17]. In all three databases synonyms
for tissue engineering (e.g. tissue engineering, tissue engineered,
regenerative medicine or biomaterials) were combined with
synonyms for urinary diversion (e.g. orthotopic diversion,
neobladders, continent or incontinent stomas). MeSH terms
(PubMed) and EMTREE terms (EMBASE) were used when
available and were combined with additional free-text words from
titles or abstracts ([tiab] or/ti,ab.). For the complete strategy, see
Table S1. In PubMed and Embase (OvidSP), the results were
filtered for animal studies, using previously designed ‘animal filters’
[18,19]. The included primary studies and relevant reviews on the
subject were screened for additional relevant references.
2. Study selection
Only primary studies that evaluated tissue engineered construct
for urinary diversion in animal models were included. From the
retrieved set of papers, duplicates and triplicates were manually
deleted from EndNote, considering the preference PubMed.
EMBASE.Web of Science. Based on title/abstract, primary
screening was performed by a single review author (MS), deleting
articles that clearly did not involve tissue engineering or urinary
diversion. In case of any doubt, articles were included for further
screening. Secondary screening of title/abstract was independently
performed in Early Review Organizing Software (EROS, IECS,
Buenos Aires, Argentina, www.eros-systematic-review.org) by two
review authors (MS and RdV). The following inclusion criteria
were used: 1) urinary diversion, 2) tissue engineering, 3) (living)
animals of any species, and 4) primary articles. In this step, a
procedure was considered to be a urinary diversion if it involved a
total/radical cystectomy or implantation of a stoma or pouch
connected to at least one ureter. Articles that described a partial
cystectomy, hemi-cystectomy or bladder augmentation were
excluded, because they do not relate to urostomy. Tissue
engineered constructs were defined as biomaterials or polymers
that aided the (re)construction of tissues. Articles were either
categorized as ‘included’, ‘excluded’ or ‘more information
necessary’ if important details were not included in the abstract.
Any discrepancies were discussed and re-evaluated until consensus
was reached. Full-text articles were retrieved and evaluated for
definite inclusion/exclusion, based on the same criteria used for
the secondary screening. The reference lists of the included studies
and manually identified reviews on the subject were screened for
any missed references. Unfortunately, one of the included studies
was published in Korean and we did not have the resources to
have it translated [20]. The article was therefore excluded from
this review.
3. Data extraction
From every included study, basic information (author, year of
publication, etc.), animal characteristics (species, sex, etc) and
study characteristics (biomaterial, follow-up, etc.) were extracted
and tabulated by MS and RdV after reaching consensus (Table 1).
The outcome of the studies for the meta-analysis was assessed
using extracted data on mortality, adverse effects, occlusion
(blockade of urinary flow) and the formation of urothelium on
the implanted construct (Table 2).
4. Methodological quality assessment
All included studies were feasibility studies only, i.e. no
comparison was made between the new (tissue engineering) and
classical treatment (GI tissue) or any other relevant control group.
Therefore, performing a risk of bias-assessment was not possible,
and we consequently focused on the quality of the reporting of
data and outcomes of the studies (Table 3).
5. Meta-analyses
Meta-analyses were performed for the outcome measures
functionality (absence of occlusion) and formation of urothelium
in seven studies. One study did not describe the animal species and
was therefore excluded [26]. Since appropriate control groups
were not included in any of the studies, it was not possible to
perform a standard meta-analysis using, for example, odds ratios.
We therefore performed a meta-analysis of proportions, more
specifically of the number of animals in which a functional
construct or urothelium was formed as a proportion of the total
number of treated animals. First, exact binomial confidence
intervals were calculated for the individual studies. To circumvent
continuity corrections (some studies had 0 events), an arcsine
transformation of the proportions was carried out for the meta-
analyses [21]. Because high heterogeneity was expected, the
individual proportions were pooled using a random effects model.
Given the low number of studies, a Hartung-Knapp adjustment
for random effects models was applied [22]. I2 was used as a
measure of heterogeneity. The analyses were conducted in R
(version 3.0.1; R Core Team 2012), using the metafor package
[23,24]. To explore the potential influence of animal size on the
effect, the studies were ranked according to the subgroups ‘‘large’’
(rabbits and larger) and ‘‘small’’ (rats and mice) models in the
forest plots. The small group sizes prevented calculation of an
overall effect per subgroup and therefore only visually derived
tendencies are presented.
Results and Discussion
1. Study inclusion
Database searches yielded 573 references for PubMed, 855
references for Embase and 315 references for Web of Science
(Figure 1). After removal of duplicates and triplicates 1157
references remained. During the primary screening in EndNote,
883 references that did not meet our inclusion criteria were
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removed. Secondary screening of the remaining 274 references in
EROS led to the removal of 206 references. Full text analyses of
the remaining 68 references resulted in the inclusion of only 8
studies: two abstracts, one poster and five full-text papers (Figure
S1). Screening of the reference lists of these papers and manually
identified relevant reviews on the subject did not yield any new
references. Thus, the final set included: Geutjes et al. (2012), Basu
et al. (2012), Kloskowski et al. (2012), Liao et al. (2013), De Filippo
et al. (2009), Bertram et al. (2009), Drewa et al. (2007), and
Dørflinger et al. (1985) [11,25–31]. Although the number of
published studies on tissue engineering for urinary diversion in
animal models appeared to be substantial, only these selected
studies applied tissue engineered constructs for urinary diversion at
relevant clinical sites in animal models. The recent increase in
published papers on this subject is remarkable. Although all
relevant databases were explored, we cannot exclude that some
data reside within company protected domains. Moreover, studies
tend to be published only when results are positive and statistically
significant [32]. These two factors may have resulted in an
incomplete data set and they may have introduced a publication
bias in this systematic review. Due to the limited number of
included studies, we were not able to estimate the risk and effect of
this publication bias.
2. Study characteristics
Analysis of study characteristics revealed extraordinary diversity
(Table 1). Various animal species, including pigs, minipigs, dogs,
rats and rabbits, were used. They were implanted with constructs
of either biodegradable polymers (poly(lactic-co-glycolic acid)
(PLGA), polyglycolic acid (PGA) or collagen) or decellularized
material (small intestinal submucosa (SIS) and bladder acellular
matrix (BAM)). Kloskowski et al., used a biodegradable polymer
polycaprolactone (PCL) and decellularized aortic arches. Although
three different approaches for urinary diversion are known
(urinary conduit, abdominal pouch and neobladder), the included
studies only created urinary conduits (5 studies) or neobladders (3
studies). An animal model for an abdominal pouch was not
described.
There are three different study designs within the pool of
included studies: studies that use cellular or acellular scaffolds and
studies that compare these two constructs (Table 1 and 4). The
most frequently used study design was the comparison between
cellular and acellular constructs (4 studies), investigating whether
(pre-)seeding of the biomaterial resulted in a superior outcome.
These studies generally isolated their cells from a bladder biopsy,
although alternative sources like adipose tissue, peripheral blood
and cell lines were investigated (Basu et al., Drewa et al., Geutjes et
al. and Liao et al.). The other studies compared different materials
(Kloskowski et al.), cell concentrations (Bertram et al.) or different
experimental designs (Dørflinger et al.). Filippo et al. compared the
behavior of a cell-seeded PLGA-based scaffold in cystectomized
animals with its behavior in children enrolled in a Phase II trial for
bladder augmentation. This diversity in animal species, biomate-
rial or study design complicates the interpretation of the results of
this systematic review.
Since tissue engineering for urinary diversion is a relatively new
area of research, the main focus of the studies was to determine the
feasibility of implantation and subsequent behavior of the designed
constructs. Follow-up time was less than a year in all cases,
whereas constructs need to be functional throughout the
remainder of a patients’ life time. Stoma complications can occur
after several years in patients, and short follow-up in animals will
not provide evidence on late complications. This indicates the
necessity of appropriate control groups with the classical
techniques and longer follow-up for at least 1 year.
3. Quality assessment
The lack of control groups precluded a risk of bias-analysis. We
therefore focused on the reporting quality of the studies (Table 3).
Our specific interests were the animal characteristics, the
composition, dimensions and preparations of the construct, the
Table 2. Scoring of the included studies.
Reference Follow-up Mortality Adverse effects
Formation
of UD
Urothelium
formation
1 Basu 2012 84+/25 days 0%a * 32/32a 32/32b
2 Bertram 2009 9 months 0%? none 24/24?c 24/24?c
3 De Filippo 2009 6 months 0%? * * *
4 Dorflinger 1985 6 months 60% hydronephrosis (5#), hydroureter (4#),
pyonephrosis (2#), inflammation (3#),
leakage (2#), infection (1#), ulcers (1#),
reflux (2#)
2/10 2/10
5 Drewa 2007 2 or 4 weeks 0% adhesion (3#), inflammation (4#),
leakage (1#), pseudocyst (1#), hydronephrosis
(4#), hydroureter (3#)
3/6 1/6
6 Geutjes 2012 1 month 11% stenosis (3#), leakage (2#),
hydroureteronephrosis (all),
hydroureter (all)
8/9 6/9
7 Kloskowski 2012 3 weeks 28%d Inflammation (all), 0/14 1/14e
8 Liao 2013 1, 2, 4 or 8 weeks 13%f scarring (4#), atresia (4#), hydronephrosis (4#),
fistulas (2#), inflammation(2#)g
26/30h 26/30h
* = not mentioned, ? = it is implied that all animals survived and formed a functional conduit with urothelial layers, a = all animals were euthanized at indicated time
points, animals remained healthy, no explicit mentioning of occlusions, b = no mentioning of place of sampling. Unclear whether it covers the entire conduit, c =
group 4 does not include TE, leaving 24 animals for UD, d = deaths were only in aortic arch group, e = mentioning of formation of cell layers, not specific on type of
cell layer, f = all animals died in the experimental group, g = complications were observed in the control group only, h = unclear if this accounts for all animals.
doi:10.1371/journal.pone.0098734.t002
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representativeness of the results and the adequate reporting of
drop-outs.
The reporting was relatively poor in the abstracts compared to
the full-text papers. Many abstracts omitted important details that
are essential to compare different studies, including animal species,
strain, number and sex, type of tissue engineered scaffolds,
description of the composition, dimensions and preparations of the
construct (Q1-Q9). This might have been partly the consequence
of the word and space limitation for abstracts.
All included studies appropriately described the predefined
outcome measures and stated at which time evaluation took place.
Only two studies commented on the representativeness of the
figures for the overall study outcomes (Dørflinger et al. and Drewa
et al.) (Q10-Q13). In total, three papers were complete in their
reporting of the study design (Drewa et al., Geutjes et al., and Liao
et al.).
Although guidelines for standardized reporting of animal
experimentation have been described, these have not yet been
generally accepted [33,34]. We observed that in some studies,
especially in the abstracts, these guidelines were not implemented.
It is crucial to further improve methodological reporting to aid
future research, even in abstracts.
4. Data synthesis
To determine the efficacy of the tissue engineered constructs, we
focused on the outcome measures: formation of a functional
conduit or reservoir and the formation of urothelium in the
regenerated tissue, evidenced by histology (Table 2). Some studies
performed additional analyses, including immunohistochemistry,
urograms or pyelograms (Table 1), but these were not considered
here. Because constructs can only be functional in the absence of
major complications (including mortality), we first looked at the
survival of the animals and adverse effects. Survival of the animals
was regarded as the first indication for the safety of a construct and
represented a condition for the efficacy of a construct. Secondly,
since urine needs to exit the body adequately, the formation of a
reservoir or conduit with a urothelial lining was deemed essential.
4.1 Adverse effects and mortality. Experience shows that
even in some situations animals might die of unrelated causes, with
more likelihood in larger experimental groups. A clear and
detailed description of the drop-outs will increase the credibility of
Figure 1. Flow-chart of search and screening process. Primary screening exclusion was performed in End-Note. Criteria included: no urinary
diversion, no tissue engineering or reconstruction of ureter or urethra. Secondary inclusion was performed in EROS. Criteria included: no urinary
diversion, no tissue engineering, no animal study or no primary study.
doi:10.1371/journal.pone.0098734.g001
Table 4. Cellular vs. Acellular.
Acellular Cellular
Basu et al 2012 8/8 24/24
Drewa et al 2007 2/3 1/3
Geutjes et al 2012* 4/4 5/6
Liao et al 2013 4/6 24/24
Amount of functional conduits formed in comparative studies with cellular and acellular groups. * was tabulated after correspondence with the first author.
doi:10.1371/journal.pone.0098734.t004
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the study. Surprisingly, two studies did not explicitly report on the
mortality rate, but the studies suggest that all animals survived the
procedure in good health (Basu et al, and Bertram et al.) They
imply that a functional urinary conduit with urothelial linings is
formed in all animals without any adverse effects (Table 2 and
Table 3, Q14-Q17). Such a successful score was not described in
any of the other studies, which raises the possibility that the success
rate was overestimated. The reported mortality of the other studies
ranged between 60% in the pioneering study in 1985 (Dørflinger
et al.) to 13% in the most recently published paper (Liao et al.),
suggesting the application of improved constructs or improved
surgical techniques over the years. Geutjes et al. is the only study
that reports on both related and unrelated deaths.
All studies report on inflammation of the construct and the
surrounding tissues, although this does not necessarily constitute a
negative effect. Some degree of inflammation may guide tissue
regeneration, remodeling and the formation of blood vessels. The
formation of a vasculature structure in large constructs still
remains a major problem in tissue engineering [35,36]. Other
common adverse effects found in the majority of the studies were
hydronephrosis and hydroureters, prevention of which remains the
biggest challenge for tissue engineers. The designed constructs
were not able to control urinary pressure, leading to reflux to the
kidney and the aforementioned conditions.
The formation of stones in urinary diversions is one of the
complications in using GI tissue. Remarkably, only one study,
performed in pigs reported the formation of calcifications (Geutjes
et al.). The absence of stones, particularly in the included rabbit
study, is unexpected (Liao et al.). Implantation of a tissue
engineered patch in the bladder wall of rabbits resulted in a high
incidence of stone formation and encrustation, indicating that this
animal model in particular is prone to develop stones [37,38].
Although a different biomaterial was used in a different setting, no
stones were formed up until two months in the study performed by
Liao et al. In humans, it takes months to years to develop urinary
stones and perhaps the follow-up time in these studies is too short
(,1 year) to detect stones [39]. Obviously, due to the difference in
diet composition, flow speed, composition and pH of urine in
different species, urinary stones might not develop in some
animals. Long-term follow-up is necessary to exclude encrustation
or stone formation.
4.2 Efficacy. We conducted meta-analyses for the outcome
measures functionality and urothelium formation (Figures 2A and
B). The aim of these meta-analyses was not to obtain a precise
point estimate, but rather to get an impression of the quantitative
relations between the results of the individual studies and to detect
trends [40]. The heterogeneity between the studies was very high
(I2 = 96% for functionality and I2 = 95% for urothelium forma-
tion). Although this did not justify pooling of the results,
nevertheless, overall proportions were calculated for functionality
and urothelium formation (69% [CI: 18–100%] and 65% [CI: 17–
98%], respectively). Due to the large heterogeneity and small
number of studies, these overall proportions should be interpreted
with caution.To prevent misinterpretations, overall proportions
are only shown as dotted vertical lines in the forest plots.
Successful formation of functional conduits with full urothelial
linings, the primary goal of all studies, varied between the studies.
Only small numbers of functional conduits and urothelial coverage
were observed by Dørflinger et al., Drewa et al. and Kloskowski
et al. In contrast, Liao et al. showed that in 4/5 cases a functional
conduit was formed with urothelial linings. The large heteroge-
neity and small number of studies complicates identification of the
underlying cause of the different results. We can only speculate
whether these were the consequence of the biomaterial, the animal
model or confounding factors.
4.3 Animal models. The small number and heterogeneity of
the studies did not permit subgroup analysis for different animal
species. However, the forest plots (Figures 2A and B) from the
meta-analyses suggested a tendency towards better results in large
animal models compared to small animals. Although we cannot
exclude the effect of confounding factors, this supports the idea
that future research should focus on larger animals. Larger
animals have a more similar anatomy to the human body than, for
example, rodents, and allow for evaluation at clinical relevant sites
with constructs of a comparable size. Moreover, surgical
techniques and materials are more comparable to the human
setting, therefore mimicking the human situation as closely as
possible. In 1985, the first report on the use of a construct to tissue
engineer a urinary diversion as a replacement for GI tissue in large
animals was published (Dørflinger et al.). Even though the
mortality rate was high, a functional reservoir could be formed
showing the feasibility of this approach. In later studies small
animals were used (Kloskowski et al. and Drewa et al.) but the
success rate in these studies was low. This might be explained by
the surgical challenge with a higher risk of complications in smaller
animals.
The extraordinary heterogeneity in animal studies has previ-
ously been reported by Roosen et al. [41], who reviewed different
animal models for the classical types of urinary diversion using GI
tissue. A uniform conclusion regarding the most suitable animal
model could not be drawn and the author advised to view the
results with caution, when translating these for clinical implemen-
tation.
4.4 Cellular and acellular scaffolds. The studies that
compared acellular and cellular scaffolds investigated the effect of
(pre-) seeding on tissue regeneration (Table 1 and 4). Basu et al.,
Liao et al. and Geutjes et al. expanded autologous cells from a
biopsy. Basu et al. stated that (pre-)seeding of the scaffolds
provided an additional advantage, although this was not
substantiated. The same conclusion was drawn by Liao et al.,
but here the authors clearly report that the drop-outs and adverse
effects in the acellular group were higher. Geutjes et al. observed
no difference between cellular and acellular constructs.
In the study by Drewa et al., scaffolds were seeded with 3T3
fibroblast from mouse origin, followed by implantation in rats. Not
surprisingly, this resulted in an excessive inflammatory response
and consequently a better outcome for the unseeded group.
The presence of a cellular component can trigger M1
macrophages, resulting in fibroblast deposition. In contrast,
acellular scaffolds activate the M2 macrophages, which leads to
reconstruction and regeneration of tissues [35]. Some researchers
have reported that scaffold (pre-)seeding provides an additional
advantage for tissue regeneration, since regeneration is less
dependent on cellular in-growth [42,43]. Since the effect pre-
seeding is outside the scope of this systematic review, a meta-
analyses was not performed. Therefore, based on the available
information, it is unclear whether (pre-)seeding of the scaffolds
provides an advantage for tissue reconstruction in urinary
diversions.
4.5 Concluding remarks. Based on this systematic review
the most adequate animal model for urinary diversion is still
undefined. Only a limited amount of studies could be identified
despite the comprehensive search strategy, all showing large
heterogeneity. It appears that the predictive value of a particular
animal model was not a decisive factor in the studies performed.
Nevertheless, the forest-plots suggested a trend towards successful
experimentation in larger animal models, supporting the idea that
Tissue Engineering in Animal Models for Urinary Diversion
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future research should focus on the evaluation of constructs in
larger animal models which more closely mimic the human body
than small (rodent) animal models. Bladder augmentations and
urethral replacements have been successful in dogs [44–47].
Although the results of the earliest study were disappointing
(Dorflinger) this might be explained by the tissue engineering
strategy. Use of a more sophisticated tissue engineering approach
did lead to satisfactory results (Bertram). In view of the former,
evaluation of urinary diversion constructs in dogs might be a valid
alternative.
Despite the limited amount of data available on this subject, a
phase I clinical trial was initiated for implantation of a (pre-)seeded
tissue-engineered urinary conduit in cystectomized patients [48].
Whether it is acceptable to expose patients to a new device which
has not been investigated in a long term and multicenter animal
study remains a matter of debate. Critics of animal experimen-
tation might say that it is difficult to find a representative animal
model to improve clinical translation. In order to improve
translational practice, a re-evaluation of preclinical practice is
warranted, in which systematic reviews and meta-analyses of
animal studies can provide a valuable tool [49].
This systematic review focused on the identification of an
appropriate animal model to investigate tissue engineering for
urinary diversion. Remarkably, only feasibility studies were
identified, which are necessary to evaluate potentially valuable
techniques. To obtain a more thorough estimation of the feasibility
and applicability, a large variety of approaches should be
investigated and should include different biomaterials, growth
factors and large animal models. Evaluation of the functionality
and advantages of newly developed constructs should include
appropriate controls and evaluate long-term effects and outcomes
to investigate safety and efficacy of these constructs. Moreover,
standardized assessment methods are desirable. The ultimate
control would be the use of GI tissue, the golden standard
technique currently used in the clinic. Assessment of these
preclinical experiments should focus on both functionality and
tissue regeneration, using urodynamic measurements and histo-
logical evaluations. To continue to clinically translatable studies,
standardization of (large) controlled and comparative studies with
adequate methodological reporting is required as laid down in
existing guidelines [33,34].
Animal experimentation remains subject to ethical debate and -
among others- for animal welfare reasons it is therefore essential
that research is properly conducted and reported. Nevertheless,
the reporting of the methodology and representativeness of results
was rather poor in the reviewed studies. Improvements in this area
are urgently needed for ethical, scientific and economic reasons,
and will allow researchers to repeat studies reliably and make an
unbiased decision on the most correct animal model for their
future experiments. The scientific community should adopt the
Figure 2. Forestplots for functionality (A) and urothelium formation (B). Forest plot of 7 studies. Filippo et al. was excluded for both meta-
analyses since the study does not report on the type of animal, functionality and urothelium formation. * indicates studies with large animal species.
doi:10.1371/journal.pone.0098734.g002
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existing guidelines for standardized reporting of animal experi-
mentation and implement them in journal author guidelines,
which should be enforced by editors, to improve standardized
reporting in full-text articles. This will aid in good quality research
with more relevant output for the clinic and reduction of the use of
animals in biomedical research.
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